For the third time in four months, Lupin Pharmaceuticals, one of India’s biggest suppliers of generic drugs to foreign markets, has been admonished by the Food and Drug Administration for a series of troubling quality-control issues at a manufacturing facility.

In a recent inspection report, the regulator cited the company for failing to thoroughly review unexplained deficiencies in batches of medicines and not taking “scientifically sound” steps to evaluate samples; delays in assessing health hazards; insufficiently investigating customer complaints, including an instance involving mold on medicines shipped to the U.S.; and a lack of oversight and training.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hi, I had a heart attack on Labor Day 9/2/2019 and feel it is the fault of this Lupin Lovistatin I began taking on 5/26/2019, after 4 years taking a different brand Teva with no problems. My yearly checkup Jan 2019 with my Cardiologist had me a 120/80 BP with over 95% hear function after 4 years since my first heart attack May of 2015. The Giant Eagle Pharmacy told me Lupin was replacing the 20mg Teva brand when I got my refill 5/26/2019. After about a month I noticed discomfort in my chest, questioned the change of brands, found out there was a recall of 40mg Lovi’s from Lupin in Feb 2019 which the pharmacy said they were aware of but the 20mg weren’t effected so I continued taking & the discomfort continued so i requested my next refill on 8/26/2019 be Teva 10mg, 2 a day which i got but the damage was done & by 9/2 I was code purple in the ER, 100% blockage of the Widowmaker & 95% of the main right artery. I know its the Lupin. Now I’m screwed, on a longer road to recovery & may never have as good a functioning heart again. If you know of anything I could do along with more info on Lupin please let me know. I live in Lorain Ohio & Thank God for the staff at Mercy Hospital for saving my life but any help in direction & support from you would be appreciated. Thanks John Jannuzzi (440)949-0352 Please send me this email back so I have a record of it also….cool

Your daily dose of news in health and medicine

Privacy Policy